Search Results - "ISHWARLAL JIALAL"

Refine Results
  1. 1

    Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective by Jialal, Ishwarlal, Kaur, Harmeet, Devaraj, Sridevi

    “…Context: The prevalence of both obesity and metabolic syndrome (MetS) is increasing at alarming rates globally. Both predispose to diabetes, cardiovascular…”
    Get full text
    Journal Article
  2. 2

    Metabolic syndrome is an inflammatory disorder: A conspiracy between adipose tissue and phagocytes by Reddy, Priya, Lent-Schochet, Daniella, Ramakrishnan, Neeraj, McLaughlin, Matthew, Jialal, Ishwarlal

    Published in Clinica chimica acta (01-09-2019)
    “…Metabolic syndrome (MetS) describes a cluster of cardio-metabolic factors that predispose to type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular…”
    Get full text
    Journal Article
  3. 3

    C-Reactive Protein Polarizes Human Macrophages to an M1 Phenotype and Inhibits Transformation to the M2 Phenotype by Devaraj, Sridevi, Jialal, Ishwarlal

    “…OBJECTIVE—Inflammation is pivotal in atherosclerosis. Monocyte-macrophages are crucial in atherosclerosis. Monocytes can develop into subsetsclassically (M1)…”
    Get full text
    Journal Article
  4. 4

    Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors by Dasu, Mohan R, Jialal, Ishwarlal

    “…Type 2 diabetes (T2DM) is characterized by hyperglycemia, dyslipidemia, and increased inflammation. Previously, we showed that high glucose (HG) induces…”
    Get more information
    Journal Article
  5. 5

    Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects by Dasu, Mohan R, Devaraj, Sridevi, Park, Samuel, Jialal, Ishwarlal

    Published in Diabetes care (01-04-2010)
    “…OBJECTIVE: Individuals with type 2 diabetes have a myriad of metabolic aberrations including increased inflammation, increasing their cardiovascular risk…”
    Get full text
    Journal Article
  6. 6

    Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy by Kaur, Harmeet, Chien, Alexander, Jialal, Ishwarlal

    “…Diabetes is a proinflammatory state. The pattern recognition receptors, Toll-like receptors (TLRs), are increased in diabetic patients and have been suggested…”
    Get more information
    Journal Article
  7. 7

    Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes by Devaraj, Sridevi, Tobias, Peter, Jialal, Ishwarlal

    Published in Cytokine (Philadelphia, Pa.) (01-09-2011)
    “…► Diabetes is a pro-inflammatory state. ► Toll like receptors 2 and 4 are increased in diabetes. ► Knockout of TLR4 attenuates inflammation in diabetic rats. ►…”
    Get full text
    Journal Article
  8. 8

    Toll-like receptors 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx by Pahwa, Roma, Nallasamy, Palanisamy, Jialal, Ishwarlal

    Published in Journal of diabetes and its complications (01-05-2016)
    “…Abstract Objectives Hyperglycemia-induced inflammation is central to the vascular complications in diabetes. Toll-like receptors (TLRs) are key players in…”
    Get full text
    Journal Article
  9. 9

    The Evolving Role of C-Reactive Protein in Atherothrombosis by Devaraj, Sridevi, Singh, Uma, Jialal, Ishwarlal

    Published in Clinical chemistry (Baltimore, Md.) (01-02-2009)
    “…Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for…”
    Get full text
    Journal Article
  10. 10

    Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden by Reddy, Priya, Leong, Joseph, Jialal, Ishwarlal

    Published in Journal of diabetes and its complications (01-05-2018)
    “…Metabolic Syndrome (MetS) is a cluster of cardio-metabolic risk factors characterized by low-grade inflammation which confers an increased risk for type 2…”
    Get full text
    Journal Article
  11. 11

    Fetuin-A is also an adipokine by Jialal, Ishwarlal, Pahwa, Roma

    Published in Lipids in health and disease (27-03-2019)
    “…Fetuin-A (FetA), which impairs insulin action is considered classically as a hepatokine. In patients with Metabolic Syndrome without the confounding of…”
    Get full text
    Journal Article
  12. 12

    Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome by Jialal, Ishwarlal, Devaraj, Sridevi, Kaur, Harmeet, Adams-Huet, Beverley, Bremer, Andrew A

    “…Context: Adipose tissue dysregulation causing aberrant adipokine secretion contributes toward the proinflammatory state of metabolic syndrome (MetS). However,…”
    Get full text
    Journal Article
  13. 13

    Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin by Yun, Jung-Mi, Jialal, Ishwarlal, Devaraj, Sridevi

    Published in The Journal of nutritional biochemistry (01-05-2011)
    “…Diabetes is a proinflammatory state. We have previously shown increased monocyte proinflammatory cytokines in patients with Type 1 and Type 2 diabetes. High…”
    Get full text
    Journal Article
  14. 14

    Hyperglycemia Induces Toll-Like Receptor-2 and -4 Expression and Activity in Human Microvascular Retinal Endothelial Cells: Implications for Diabetic Retinopathy by Rajamani, Uthra, Jialal, Ishwarlal

    Published in Journal of diabetes research (01-01-2014)
    “…Diabetic retinopathy (DR) causes visual impairment in working age adults and hyperglycemia-mediated inflammation is central in DR. Toll-like receptors (TLRs)…”
    Get full text
    Journal Article
  15. 15

    Increased mast cell abundance in adipose tissue of metabolic syndrome: relevance to the proinflammatory state and increased adipose tissue fibrosis by Gurung, Purnima, Moussa, Karine, Adams-Huet, Beverley, Devaraj, Sridevi, Jialal, Ishwarlal

    “…Metabolic Syndrome (MetS) affects 35% of American adults > 40 yr and portends an increased risk for both atherosclerotic cardiovascular disease (ASCVD) and…”
    Get more information
    Journal Article
  16. 16

    Adipose Tissue Dysfunction in Nascent Metabolic Syndrome by Bremer, Andrew A., Jialal, Ishwarlal

    Published in Journal of Obesity (01-01-2013)
    “…The metabolic syndrome (MetS) confers an increased risk for both type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). Moreover, studies on adipose…”
    Get full text
    Journal Article
  17. 17

    Correlates of Insulin Resistance in Nascent Metabolic Syndrome by Adams-Huet, Beverley, Jialal, Ishwarlal

    “…Background: Metabolic Syndrome (MetS), a major global problem, is a cluster of cardio-metabolic risk factors that predisposes to both type 2 diabetes mellitus…”
    Get full text
    Journal Article
  18. 18

    Global toll-like receptor 4 knockout results in decreased renal inflammation, fibrosis and podocytopathy by Jialal, Ishwarlal, Major, Angela M, Devaraj, Sridevi

    Published in Journal of diabetes and its complications (01-11-2014)
    “…Abstract Background and purpose Type 1 diabetes mellitus (T1DM) is a pro-inflammatory state with increased toll-like receptor (TLR) activity. Inflammation is…”
    Get full text
    Journal Article
  19. 19

    Modulating inflammation to reduce atherosclerotic cardiovascular events: should colchicine be part of the therapeutic regimen? by Jialal, Ishwarlal, Vikram, Naval

    “…In a previous editorial in this journal we reviewed the large Canakinumab Anti-Inflammatory Thrombosis Outcome Study (CANTOS) and concluded based on the…”
    Get full text
    Journal Article
  20. 20

    Increased adipose tissue secretion of Fetuin-A, lipopolysaccharide-binding protein and high-mobility group box protein 1 in metabolic syndrome by Jialal, Ishwarlal, Devaraj, Sridevi, Bettaieb, Ahmed, Haj, Fawaz, Adams-Huet, Beverley

    Published in Atherosclerosis (01-07-2015)
    “…Abstract Objective Adipose Tissue (AT) dysregulation contributes to the pro-inflammatory state and insulin resistance of Metabolic Syndrome (MetS). We examined…”
    Get full text
    Journal Article